设计,分子对接,体外和体外评估Dimenhydrinate-Cyclodextrin复合物用于快速分解的平板电脑
Randa Khalid Samara1, Rana M F Sammour2, Veronique Seidel3
1Emirates Health Services, Dubai, United Arab Emirates.
Current pharmaceutical design
|June 17, 2025
概括
这项研究开发了与β-cyclodextrin (β-CD) 复合的双氨酸 (DMH) 快速分解片 (FDTs). 这些增强的DMH FDT显示出更好的溶解性,溶解性和药理性能,以获得更好的患者结果.
科学领域:
- 制药科学 制药科学
- 药物输送系统 药物输送系统
- 药用化学 医学化学
背景情况:
- 丁氨酸 (DMH) 具有较差的溶解性和溶解性,限制了其治疗疗效.
- 快速分解片 (FDTs) 提供了改善的患者服药性和更快的药物吸收.
- β-cyclodextrin (β-CD) 是一种潜在的复合剂,可以增强药物溶解性.
研究的目的:
- 为了制定和评估二门氨酸 (DMH) 作为快速分解片 (FDTs) 复合与β-cyclodextrin (β-CD).
- 提高DMH的可溶性,溶解概况和药理性能.
- 优化FDT配方,以改善药物输送.
主要方法:
- 使用 1:1 率的制方法制备了一个DMH:β-CD 合复合物.
- 描述包括相位溶解性研究,FTIR分析,分子对接和体外溶解试验.
- 用各种超级分解剂开发了FDT,并对平板电脑质量属性进行了评估.
主要成果:
- 阶段溶解性和FTIR证实了稳定的DMH:β-CD复合物的形成.
- 分子对接揭示了β-CD和二氨酸之间 -4.2 kcal/mol的结合亲和力.
- 优化的FDT (CP3与9%的crospovidone) 呈现出快速分解 (4.3s) 和增强的药物释放,改善了体内镇静剂和抗活动.
结论:
- 结合FDT技术的循环德克斯复合剂显著提高了DMH的药理疗效和患者遵守性.
- 开发的DMH:β-CD FDTs在溶解性,溶解性和治疗性能方面显示出有前途的改善.
- 建议对长期稳定性,药理动力学和临床可扩展性进行进一步研究.
相关概念视频
Factors Influencing Drug Absorption: Pharmaceutical Parameters
198
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
198
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
269
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
269
Factors Affecting Dissolution: Particle Size and Effective Surface Area
1.1K
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
1.1K
Factors Influencing Drug Absorption: Drug Dissolution
734
The pharmacokinetic journey of drugs from solid oral dosage forms into systemic circulation is multifaceted. It begins with disintegration, a prerequisite ensuring a solid dosage form's subdivision into minute particles. Dissolution occurs next as these granulated entities solubilize in gastrointestinal fluids. This solubilization is crucial for the succeeding stage, permeation, which describes the traversal of the drug across the intestinal membrane and its subsequent entry into the blood...
734
Factors Influencing Drug Absorption: Physicochemical Parameters
458
The physicochemical characteristics of drugs play a crucial role in formulating stable and bioavailable drug products. The solubility of a drug, governed by the varying pH along the GI tract and its dissociation constant (pKa), is pivotal in determining its ionization state and absorption rate. Notably, weak acids and bases remain unionized and are absorbed more rapidly.
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
458
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
407
Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
407


